Literature DB >> 30066113

Substance Use and Adherence to Antiretroviral Therapy: What Is Known and What Is Unknown.

M Eugenia Socias1,2, M-J Milloy3,4.   

Abstract

PURPOSE OF REVIEW: People who use drugs face multiple challenges to achieve optimal HIV treatment outcomes. This review discusses the current knowledge in substance use and antiretroviral therapy adherence, highlighting recent findings and potential interventions. RECENT
FINDINGS: Studies continue to demonstrate the negative impacts of substance use and related disorders on antiretroviral therapy adherence, with the exception of cannabis. Evidence-based addiction treatment, in particular, opioid agonist therapy, appears to improve adherence levels. Most individual-level adherence specific interventions did not provide sustained effects, and no studies evaluating structural-level interventions were found. Findings suggest the urgent need to scale-up opioid agonist therapy, as well as to simultaneously address multiple structural barriers to care to optimize HIV treatment outcomes among people who use drugs.

Entities:  

Keywords:  Adherence; Antiretroviral therapy; Cannabis; Opioid agonist therapy; People who inject drugs; People who use drugs

Year:  2018        PMID: 30066113      PMCID: PMC6375705          DOI: 10.1007/s11908-018-0636-7

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  57 in total

1.  Methamphetamine use and neuropsychiatric factors are associated with antiretroviral non-adherence.

Authors:  David J Moore; Kaitlin Blackstone; Steven Paul Woods; Ronald J Ellis; J Hampton Atkinson; Robert K Heaton; Igor Grant
Journal:  AIDS Care       Date:  2012-04-24

Review 2.  Substance use: impact on adherence and HIV medical treatment.

Authors:  Adam Gonzalez; Jennifer Barinas; Conall O'Cleirigh
Journal:  Curr HIV/AIDS Rep       Date:  2011-12       Impact factor: 5.071

3.  Effect of Patient Navigation With or Without Financial Incentives on Viral Suppression Among Hospitalized Patients With HIV Infection and Substance Use: A Randomized Clinical Trial.

Authors:  Lisa R Metsch; Daniel J Feaster; Lauren Gooden; Tim Matheson; Maxine Stitzer; Moupali Das; Mamta K Jain; Allan E Rodriguez; Wendy S Armstrong; Gregory M Lucas; Ank E Nijhawan; Mari-Lynn Drainoni; Patricia Herrera; Pamela Vergara-Rodriguez; Jeffrey M Jacobson; Michael J Mugavero; Meg Sullivan; Eric S Daar; Deborah K McMahon; David C Ferris; Robert Lindblad; Paul VanVeldhuisen; Neal Oden; Pedro C Castellón; Susan Tross; Louise F Haynes; Antoine Douaihy; James L Sorensen; David S Metzger; Raul N Mandler; Grant N Colfax; Carlos del Rio
Journal:  JAMA       Date:  2016-07-12       Impact factor: 56.272

4.  Level of adherence and HIV RNA suppression in the current era of highly active antiretroviral therapy (HAART).

Authors:  Shilpa Viswanathan; Roger Detels; Shruti H Mehta; Bernard J C Macatangay; Gregory D Kirk; Lisa P Jacobson
Journal:  AIDS Behav       Date:  2015-04

5.  Cannabis Use, Medication Management and Adherence Among Persons Living with HIV.

Authors:  Denise C Vidot; Brenda Lerner; Raul Gonzalez
Journal:  AIDS Behav       Date:  2017-07

6.  Factors linked to transitions in adherence to antiretroviral therapy among HIV-infected illicit drug users in a Canadian setting.

Authors:  Brenden Joseph; Thomas Kerr; Cathy M Puskas; Julio Montaner; Evan Wood; M-J Milloy
Journal:  AIDS Care       Date:  2015-04-27

7.  Substance use predictors of poor medication adherence: the role of substance use coping among HIV-infected patients in opioid dependence treatment.

Authors:  Adam Gonzalez; Matthew J Mimiaga; Jared Israel; C Andres Bedoya; Steven A Safren
Journal:  AIDS Behav       Date:  2013-01

8.  Substance Use and Adherence Among People Living with HIV/AIDS Receiving cART in Latin America.

Authors:  Raquel B De Boni; Bryan E Shepherd; Beatriz Grinsztejn; Carina Cesar; Claudia Cortés; Denis Padgett; Eduardo Gotuzzo; Pablo F Belaunzarán-Zamudio; Peter F Rebeiro; Stephany N Duda; Catherine C McGowan
Journal:  AIDS Behav       Date:  2016-11

9.  Factors associated with optimal pharmacy refill adherence for antiretroviral medications and plasma HIV RNA non-detectability among HIV-positive crack cocaine users: a prospective cohort study.

Authors:  Kanna Hayashi; Evan Wood; Thomas Kerr; Huiru Dong; Paul Nguyen; Cathy M Puskas; Silvia Guillemi; Julio S G Montaner; Michael-John Milloy
Journal:  BMC Infect Dis       Date:  2016-08-27       Impact factor: 3.090

Review 10.  Impact of Opioid Substitution Therapy on Antiretroviral Therapy Outcomes: A Systematic Review and Meta-Analysis.

Authors:  Andrea J Low; Gitau Mburu; Nicky J Welton; Margaret T May; Charlotte F Davies; Clare French; Katy M Turner; Katharine J Looker; Hannah Christensen; Susie McLean; Tim Rhodes; Lucy Platt; Matthew Hickman; Andy Guise; Peter Vickerman
Journal:  Clin Infect Dis       Date:  2016-06-25       Impact factor: 9.079

View more
  10 in total

1.  Longitudinal patterns of illicit drug use, antiretroviral therapy exposure and plasma HIV-1 RNA viral load among HIV-positive people who use illicit drugs.

Authors:  Jiaming Liang; Ekaterina Nosova; Hudson Reddon; Seonaid Nolan; Eugenia Socías; Rolando Barrios; M-J Milloy
Journal:  AIDS       Date:  2020-07-15       Impact factor: 4.177

Review 2.  ART Adherence Among Men Who Have Sex with Men Living with HIV: Key Challenges and Opportunities.

Authors:  Katherine G Quinn; Dexter R Voisin
Journal:  Curr HIV/AIDS Rep       Date:  2020-08       Impact factor: 5.071

Review 3.  Prisons: ignore them at our peril.

Authors:  Adeeba Kamarulzaman; Annette Verster; Frederick L Altice
Journal:  Curr Opin HIV AIDS       Date:  2019-09       Impact factor: 4.283

4.  Age matters: differences in correlates of self-reported HIV antiretroviral treatment adherence between older and younger Black men who have sex with men living with HIV.

Authors:  Matt G Mutchler; Laura M Bogart; David J Klein; Glenn J Wagner; Ian A Klinger; Keshav Tyagi; Bryce McDavitt
Journal:  AIDS Care       Date:  2019-05-09

5.  Engagement in Mental Health Care is Associated with Higher Cumulative Drug Exposure and Adherence to Antiretroviral Therapy.

Authors:  Ryan P Coyle; Christopher D Schneck; Mary Morrow; Stacey S Coleman; Edward M Gardner; Jia-Hua Zheng; Lucas Ellison; Lane R Bushman; Jennifer J Kiser; Samantha Mawhinney; Peter L Anderson; Jose R Castillo-Mancilla
Journal:  AIDS Behav       Date:  2019-12

6.  Mediators and moderators of ART adherence effects of supporting treatment adherence readiness through training (START): evidence that START helps vulnerable clients achieve better adherence.

Authors:  Glenn J Wagner; Rachana Seelam; Risa Hoffman; Bonnie Ghosh-Dastidar
Journal:  AIDS Care       Date:  2021-11-21

7.  Examining Factors Associated with Gender Identity Among Individuals Disengaged from HIV Care in Argentina.

Authors:  Pablo D Radusky; Ines Aristegui; Lissa N Mandell; Emanuel Dell'Isola; Virginia Zalazar; Nadir Cardozo; María L Alcaide; Stephen M Weiss; Deborah L Jones; Omar Sued
Journal:  Int J Behav Med       Date:  2021-05-06

8.  Polysubstance use and adherence to antiretroviral treatment in the Miami Adult Studies on HIV (MASH) cohort.

Authors:  Abraham Degarege; Karl Krupp; Javier Tamargo; Sabrina Sales Martinez; Adriana Campa; Marianna Baum
Journal:  AIDS Care       Date:  2021-03-05

9.  Performance of a short, self-report adherence scale in a probability sample of persons using HIV antiretroviral therapy in the United States.

Authors:  Ira B Wilson; Yunfeng Tie; Mabel Padilla; William H Rogers; Linda Beer
Journal:  AIDS       Date:  2020-12-01       Impact factor: 4.632

Review 10.  Confound, Cause, or Cure: The Effect of Cannabinoids on HIV-Associated Neurological Sequelae.

Authors:  Alexander Starr; Kelly L Jordan-Sciutto; Eugene Mironets
Journal:  Viruses       Date:  2021-06-26       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.